Pulmatrix (PULM) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Pulmatrix (PULM) is Moderate Underperform.

The composite score behind that read is -0.24, weighing +0.01 of bullish evidence against -0.50 bearish.

Pulmatrix last closed at $1.46, -4.58% on the session.

Against the IVW growth benchmark the position is -5.38% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for PULM so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Pulmatrix in the 9th percentile on return on equity, where 100 is best.

Pulmatrix is classified under Health Care / Pharmaceuticals, with a market capitalisation of $5.58M.

StockMap tracks Pulmatrix as the 135th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Pulmatrix ranks 118th of 151 in the group, against a group median of -0.08.